Note that some links may require registration or subscription.
Israel approved a third shot of Pfizer’s COVID-19 vaccine for citizens over 60 years of age. (Times of Israel)
As of Friday at 8 a.m. EDT, the unofficial COVID-19 toll in the U.S. included 34,754,758 cases and 612,129 deaths, increases of 79,399 and 324, respectively, compared to this time a day ago.
COVID-19-related hospitalizations are threefold higher in states where the fully vaccinated rate remains stuck below 50%. (CNN)
But “LOCK YOUR DOORS, KIDS,” President Biden is “sending goons DOOR-TO-DOOR to make you take a COVID-19 vaccine,” according to texts and Facebook ads peddled by the conservative youth group Turning Point USA. (Washington Post)
According to the latest CDC numbers, two-thirds of the vaccine-eligible U.S. population (ages 12 and up) have received at least one shot, with 57.7% now fully vaccinated.
In Louisiana, a judge is slashing community service hours in exchange for a COVID shot. (AP via KLFY)
A whopping 70% of U.S. counties fall under the CDC’s new masking recommendations for areas with substantial or high transmission. (Reuters)
Disney theme parks will follow the new guidance and again require masks indoors, vaccinated or not. (ABC7)
White-tailed deer — part of the cervid family — are just like us, at least in the sense that they’re susceptible to SARS-CoV-2 infection, according to serum samples from the Department of Agriculture’s Animal and Plant Health Inspection Service.
All Americans can get free pre-exposure prophylaxis (PrEP) for HIV, unless … they don’t have health insurance. (NPR)
Globally, an ambitious plan to control HIV/AIDS missed all of its targets — whether it be new infections in children, adolescents, and young women; or getting HIV-positive kids onto medication. (NPR)
A lawsuit from the National Council of Negro Women alleges that Johnson & Johnson targeted Black women with years’ of talcum powder advertising. (FiercePharma)
In a phase III trial of moderate-to-severe chronic spontaneous urticaria, adding dupilumab (Dupixent) to standard of care significantly improved patients’ symptoms of itch and hives, Regeneron and Sanofi announced.
Wondering what’s up at FDA? The agency allowed Emergent BioSolutions’ troubled Baltimore-area plant to again produce ingredients for Johnson & Johnson’s COVID jab. (CNN)
Meanwhile, GlaxoSmithKline announced another FDA approval for mepolizumab (Nucala), this time for adults with chronic rhinosinusitis and nasal polyps.
And AbbVie got a label expansion for onabotulinumtoxinA (Botox) for treating upper limb spasticity in eight more muscles.
Janssen announced approval of selexipag (Uptravi) for intravenous use in certain adults with pulmonary arterial hypertension who are temporarily unable to take oral therapy.
Lastly, the agency took aim at Amazon and eBay, slapping the sites with a strongly worded “untitled letter” concerning sellers hocking “potentially dangerous” weight loss and male enhancement products.
Okay, one more: AstraZeneca said it would seek FDA approval for its COVID-19 vaccine later this year. (AP)
Last Updated July 30, 2021